Skip to main content

FDA - DEA- NIH - NIDA - Controlling Cannabis




According to the National Institute of Health (NIH), "medicines today are expected to be of known composition and quality. Even in cases where marijuana can provide relief of symptoms, the crude plant mixture does not meet this modern expectation. The future of medical marijuana lies in classical pharmacological drug development, and indeed there has been a resurgence of scientific, as well as public, interest in the therapeutic applications of cannabinoids."  

Further - "Current scientific accomplishments have propelled interest in developing new drugs that can treat more effectively or more safely the constellation of symptoms for which cannabinoids might have therapeutic benefit  Through the process of what is referred to as “rational drug design,” scientists manipulate the chemical structures of known cannabinoids to design better therapeutic agents."

Under the Controlled Substances Act, cannabis is a schedule 1 drug and participating countries are required to restrict production, manufacture, possession and distribution of cannabis except for medical and scientific purposes.

The DEA regulates the cultivation of cannabis for research purposes through licensing requirements and establishing production quotas under the authority of the CSA.

 To conduct clinical drug research with Cannabis in the US, researchers are required to file an Investigational New Drug (IND) application with the FDA, obtain a Schedule 1 license from the US DEA and obtain approval from the National Institute on Drug Abuse (NIDA). The NIDA, an institute of the National Institute of Health (NIH), is the only organization in the US licensed by the DEA to manufacture and distribute cannabis for research purposes. This function is performed under its Drug Supply Program. Through the program, the NIDA arranges for cannabis to be grown and processed through contracts with two organizations: the University of Mississippi and the Research Triangle Institute. 

This elaborate control began with The Flexner report of 1910 and the recommendations it contained including :
  • Train physicians to practice in a scientific manner and engage medical faculty in research;
  • Give medical schools control of clinical instruction in hospitals
  • Strengthen state regulation of medical licenses 
From this report, medicine was changed forever.  Medicine from natural healing products became known as quackery while lab based synthetic drugs - based on "science" - became known as "safe and effective" sound medicine. 

The following has noted, extensively:

"Naturopathic and homeopathic medicine, medical care focused on unpatentable, uncontrollable natural remedies and cures was now dismissed as quackery; only drug-based allopathic medicine requiring expensive medical procedures and lengthy hospital stays was to be taken seriously...
It should also be noted that drug approval by the FDA permits the drug's manufacturer to market it for the treatment of a single specific symptom or condition. This "one pill for one symptom or condition" mindset, allows for a plethora of drugs with side effects.

Comments

Popular posts from this blog

The emerging FinTech (Financial Technology) Industry has the traditional banking industry shaking in their boots over fears of reduced profits. The Big Banks' Big Auditors' have all issued publications regarding "Banking Disruptive" and the threat of the emerging FinTech market's effect on the Big Banks' bottom line. Canada's Big Six banks earned a combined net income of CA$34.9 BILLION in 2015 and it is these outrageous profits that provide a very attractive incentive for players outside the traditional banking system. A 2014 publication by Deloitte entitled "Banking Disruptive"    states the following: "Bank employees have historically been heavily incentivised to ensure customers opening current accounts are cross-sold credit cards and other loans and, in turn, insurance policies linked to these loans. Convenience and customers' lack of financial sophistication enabled banks to make high margins on these adjacent pro...

Lies of the United Nation and Cannabis

Plant or Pills On March 25, 1972, the Final Act to the Single Convention on Narcotic Drugs, 1961, as Amended by the 1972 Protocol Amendment , was signed.  Although not self-executing, the provisions of the Single Convention must be incorporated into the domestic law by legislative acts in the signing party's country.  The Preamble to this International treaty, states the aim, purpose and justification for the Convention: "PREAMBLE The Parties, Concerned with the health and welfare of mankind,  Recognizing that the medical use of narcotic drugs continues to be indispensable for the relief of pain and suffering and that adequate provision must be made to ensure the availability of narcotic drugs for such purposes,  Recognizing that addiction to narcotic drugs constitutes a serious evil for the individual and is fraught with social and economic danger to mankind,  Conscious of their duty to prevent and combat this evil, Conside...

Happy Liver - How YOU can Improve your Liver's Function

  Liver disease is a world wide problem and it is estimated that one in ten people have developed some form of liver disease. Unfortunately in western medicine, liver disease is commonly misdiagnosed until the disease is in an advanced stage. At this point, conventional western medicine will often prescribe chemically laden pills that mostly exasperate the problem. In addition, a large variance exists between conventional chemically laden pharmaceutical pills and that of natural plant based whole medicine. Our liver is an amazing essential organ as it is able to regenerate itself, even when functioning at only 25%. One of its main roles in our bodies is detoxification. Unfortunately the amount of toxins in our everyday life impairs our liver's ability to optimally function. The above  book describes the importance of our liver for vitality, energy and beauty, not to mention our overall health.  The above book - Happy Liver by Ryder Management Inc also introduc...